|
S.N. Ivanov, A.Yu. Kochish, E.V. Sannikova
EXPERIENCE OF THE CREATING OF THE SERVICE OF SECONDARY PREVENTION OF OSTEOPOROTIC BONE FRACTURES IN RSRITO N.A. R.R.VREDEN
|
№s4-15 / 2015
|
|
I.A. Skripnikova
THE ACTIVE VITAMIN D METABOLITES FOR OSTEOPOROSIS TREATMENT AND FRACTURE PREVENTION
|
№s4-15 / 2015
|
|
L.A. Marchenkova
POSTMENOPAUSAL OSTEOPOROSIS AS A MEDICAL-SOCIAL AND ECONOMIC PROBLEM OF THE XXI CENTURY
|
№s4-15 / 2015
|
|
S.G. Anikin, T.A. Korotkova
THE USE OF ALENDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS
|
№7 / 2015
|
|
S.N. Ivanov (1), A.Yu. Kochish (1), L.B. Reznik (2), E.V. Sannikova (1)
VIEW OF ORTHOPEDIST-TRAUMATOLOGIST ON THE POSSIBILITY OF USING TERIPARATIDE IN PATIENTS WITH OSTEOPOROTIC BONE FRACTURES
|
№7 / 2015
|
|
A.Yu. Kochish, S.N. Ivanov
CASE OF OSTEONECROSIS OF THE MAXILLA IN PATIENT WITH POSTMENOPAUSAL OSTEOPOROSIS AGAINST THE BACKGROUND OF PROLONGED TREATMENT WITH ANTIRESORPTIVE DRUGS
|
№5 / 2015
|
|
A.Yu. Kochish, S.N. Ivanov, E.V. Sannikova
ADHERENCE TO THE DIAGNOSIS OF OSTEOPOROSIS IN PATIENTS WITH LOW-ENERGY FRACTURES
|
№5 / 2015
|
|
I.Yu. Golovach
SKLEROSTIN AND ITS INHIBITORS - A NEW CONCEPT IN THE TREATMENT OF BONE DISORDERS: CERTAIN PAST, PROMISING FUTURE
|
№5 / 2015
|
|
I.V. Menshikova
SECONDARY OSTEOPOROSIS IN RHEUMATIC DISEASES
|
№s5-14 / 2014
|
|
E.V. Doskina
DIABETES MELLITUS AND OSTEOPOROSIS. ANALYSIS OF COMBINED APPROACH TO THE TREATMENT
|
№s5-14 / 2014
|
|
A.Yu.Kochish, MD, S.N. Ivanov
COMPARATIVE EVALUATION OF THE EFFECTIVENESS OF DOMESTIC GENERICS AND ORIGINAL DRUG OF ZOLEDRONIC ACID IN PATIENTS WITH LOW-ENERGY VERTEBRAL FRACTURES AND POSTMENOPAUSAL OSTEOPOROSIS
|
№s5-14 / 2014
|
|
E.V. Biryukova
POTENTIALS FOR THE USE OF ZOLENDRONATE IN THE TREATMENT OF OSTEOPOROSIS
|
№s5-14 / 2014
|
Русский
